Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Oncology Drugs Global Market Report 2022

Starting Price : $5000.00 $4000.00 | Pages : 300 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, brain tumor, and other different cancer types.

The main types of oncology drugs are lung cancer drugs, pancreatic cancer drugs, breast cancer drugs, prostate cancer drugs, ovarian cancer drugs, colorectal cancer drugs, gastric cancer drugs, kidney cancer drugs, brain tumor drugs, thyroid cancer drugs, skin cancer drugs, bladder cancer drugs, cervical cancer drugs, blood cancer drugs and others (kaposi sarcoma, aids-related lymphoma, anal cancer, bone cancer, retinoblastoma, testicular cancer, hepatocellular (liver) cancer, mouth cancer, neuroblastoma). Breast cancer drugs are used to target and destroy breast cancer cells. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global oncology drugs market size is expected to grow from $199.95 billion in 2021 to $223.21 billion in 2022 at a compound annual growth rate (CAGR) of 11.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oncology drugs market is expected to reach $540.60 billion in 2026 at a CAGR of 24.8%.

The outbreak of the Coronavirus disease (COVID-19) has acted as a significant restraint on the oncology drugs market in 2020 as supply chains were disrupted due to restrictions on trade of pharmaceutical ingredients and products across countries. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China and spread globally including Western Europe, North America and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of lockdown and the outbreak had a negative impact on businesses throughout 2020 and into 2021. Pharmaceutical markets such as this one has been relatively unaffected however due to continued availability of drugs during government lock downs and inelasticity of demand. It is expected that the oncology market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy.

Companies in the oncology drugs market are increasingly investing in technologies such as artificial intelligence (AI) to save time and reduce research and development costs. AI is the simulation of human intelligence processes by machines, especially computer systems, which has the potential to surpass human intelligence levels. This technology helps to analyze large sets of chemical and biological data to identify potential drug candidates with higher success rates and at a quicker pace when compared to human analysis. The technology also helps in speeding up the patient recruitment process by matching cancer patients with the most relevant clinical trials, thus lowering clinical trial costs. Major oncology drug manufacturers such as Roche, Pfizer and Johnson and Johnson have already invested in AI technologies to reduce time taken and costs incurred for drug development. For example, Johnson and Johnson has recently entered into an agreement with BenevolentAI, a UK-based start-up, to mine data for designing new oncology drugs.

Companies in the oncology drug market are investing in targeted therapy, which has proven to be less toxic compared to traditional treatment options. Targeted cancer therapies are drugs or substances which block the growth of cancer by interfering with molecules that are more specifically involved in cancer cell progression than in normal cell activity. The goal of these therapies is to eliminate cancerous cells in the body while leaving normal cells unharmed. By focusing on changes in the cell that are specific to cancer, this therapy may prove to be more effective than traditional chemotherapy and radiotherapy. Companies in oncology market such as Pfizer, Novartis and Abbvie have understood the importance of this treatment method and are increasingly investing in it. According to a report by QuintilesIMS, 87% of the drugs currently in pipeline constitute of targeted therapy drugs.

Major companies in the oncology drugs market include F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc, Bayer AG, and Takeda Pharmaceticals.

North America was the largest region in the oncology drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period The regions covered in the oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oncology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global oncology drugs market is segmented -

1) By Type: Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Book your 30 minutes free consultation with our research experts

Contact Us

    Table Of Contents

    1. Executive Summary

    2. Report Structure

    3. Oncology Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Oncology Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Oncology Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Oncology Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Oncology Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Oncology Drugs

    9. Oncology Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Oncology Drugs Market Regional Analysis

    10.1. Global Oncology Drugs Market, 2021, By Region, Value ($ Billion)

    10.2. Global Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    10.3. Global Oncology Drugs Market, Growth And Market Share Comparison, By Region

    11. Oncology Drugs Market Segmentation

    11.1. Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Lung Cancer Drugs

    Pancreatic Cancer Drugs

    Breast Cancer Drugs

    Prostate Cancer Drugs

    Ovarian Cancer Drugs

    Colorectal Cancer Drugs

    Gastric Cancer Drugs

    Kidney Cancer Drugs

    Brain Tumor Drugs

    Thyroid Cancer Drugs

    Skin Cancer Drugs

    Bladder Cancer Drugs

    Cervical Cancer Drugs

    Blood Cancer Drugs

    Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

    11.2. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Oncology Drugs Market Metrics

    12.1. Oncology Drugs Market Size, Percentage Of GDP, 2016-2026, Global

    12.2. Per Capita Average Oncology Drugs Market Expenditure, 2016-2026, Global

    13. Asia-Pacific Oncology Drugs Market

    13.1. Asia-Pacific Oncology Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Oncology Drugs Market Metrics

    13.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Asia-Pacific Countries

    13.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Asia-Pacific Countries

    13.6. Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7. Asia-Pacific Oncology Drugs Market: Country Analysis

    13.7.1. China Oncology Drugs Market

    13.7.1.1. China Oncology Drugs Market Overview

    13.7.1.2. China Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.1.3. China Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2. Australia Oncology Drugs Market

    13.7.2.1. Australia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2.2. Australia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.3. Hong Kong Oncology Drugs Market

    13.7.3.1. Hong Kong Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4. India Oncology Drugs Market

    13.7.4.1. India Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4.2. India Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5. Indonesia Oncology Drugs Market

    13.7.5.1. Indonesia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5.2. Indonesia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6. Japan Oncology Drugs Market

    13.7.6.1. Japan Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6.2. Japan Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.7. Malaysia Oncology Drugs Market

    13.7.7.1. Malaysia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.8. New Zealand Oncology Drugs Market

    13.7.8.1. New Zealand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.9. Philippines Oncology Drugs Market

    13.7.9.1. Philippines Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.10. Singapore Oncology Drugs Market

    13.7.10.1. Singapore Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11. South Korea Oncology Drugs Market

    13.7.11.1. South Korea Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11.2. South Korea Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.12. Thailand Oncology Drugs Market

    13.7.12.1. Thailand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.13. Vietnam Oncology Drugs Market

    13.7.13.1. Vietnam Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14. Western Europe Oncology Drugs Market

    14.1. Western Europe Oncology Drugs Market Overview

    14.2. Western Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    14.3. Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    14.4. Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Oncology Drugs Market Metrics

    14.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Western Europe Countries

    14.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Western Europe Countries

    14.6. Western Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7. Western Europe Oncology Drugs Market: Country Analysis

    14.7.1. Austria Oncology Drugs Market

    14.7.1.1. Austria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.2. Belgium Oncology Drugs Market

    14.7.2.1. Belgium Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.3. Denmark Oncology Drugs Market

    14.7.3.1. Denmark Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.4. Finland Oncology Drugs Market

    14.7.4.1. Finland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5. France Oncology Drugs Market

    14.7.5.1. France Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5.2. France Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6. Germany Oncology Drugs Market

    14.7.6.1. Germany Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6.2. Germany Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.7. Ireland Oncology Drugs Market

    14.7.7.1. Ireland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.8. Italy Oncology Drugs Market

    14.7.8.1. Italy Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.9. Netherlands Oncology Drugs Market

    14.7.9.1. Netherlands Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.10. Norway Oncology Drugs Market

    14.7.10.1. Norway Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.11. Portugal Oncology Drugs Market

    14.7.11.1. Portugal Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.12. Spain Oncology Drugs Market

    14.7.12.1. Spain Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.13. Sweden Oncology Drugs Market

    14.7.13.1. Sweden Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.14. Switzerland Oncology Drugs Market

    14.7.14.1. Switzerland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15. UK Oncology Drugs Market

    14.7.15.1. UK Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15.2. UK Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15. Eastern Europe Oncology Drugs Market

    15.1. Eastern Europe Oncology Drugs Market Overview

    15.2. Eastern Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    15.3. Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    15.4. Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Oncology Drugs Market Metrics

    15.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Eastern Europe Countries

    15.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Eastern Europe Countries

    15.6. Eastern Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7. Eastern Europe Oncology Drugs Market: Country Analysis

    15.7.1. Czech Republic Oncology Drugs Market,  

    15.7.1.1. Czech Republic Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.2. Poland Oncology Drugs Market

    15.7.2.1. Poland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.3. Romania Oncology Drugs Market

    15.7.3.1. Romania Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4. Russia Oncology Drugs Market

    15.7.4.1. Russia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4.2. Russia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16. North America Oncology Drugs Market

    16.1. North America Oncology Drugs Market Overview

    16.2. North America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    16.3. North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    16.4. North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    16.5. North America, Oncology Drugs Market Metrics

    16.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, North America Countries

    16.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, North America Countries

    16.6. North America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7. North America Oncology Drugs Market: Country Analysis

    16.7.1. Canada Oncology Drugs Market

    16.7.1.1. Canada Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.2. Mexico Oncology Drugs Market

    16.7.2.1. Mexico Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3. USA Oncology Drugs Market

    16.7.3.1. USA Oncology Drugs Market Overview

    16.7.3.2. USA Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3.3. USA Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17. South America Oncology Drugs Market

    17.1. South America Oncology Drugs Market Overview

    17.2. South America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    17.3. South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    17.4. South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    17.5. South America, Oncology Drugs Market Metrics

    17.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, South America Countries

    17.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, South America Countries

    17.6. South America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7. South America Oncology Drugs Market: Country Analysis

    17.7.1. Argentina Oncology Drugs Market

    17.7.1.1. Argentina Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2. Brazil Oncology Drugs Market

    17.7.1.1. Brazil Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2.2. Brazil Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.3. Chile Oncology Drugs Market

    17.7.3.1. Chile Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.4. Colombia Oncology Drugs Market

    17.7.4.1. Colombia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.5. Peru Oncology Drugs Market

    17.7.5.1. Peru Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.6. Venezuela Oncology Drugs Market

    17.7.6.1. Venezuela Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18. Middle East Oncology Drugs Market

    18.1. Middle East Oncology Drugs Market Overview

    18.2. Middle East, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    18.3. Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    18.4. Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Oncology Drugs Market Metrics

    18.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Middle East Countries

    18.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Middle East Countries

    18.6. Middle East Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7. Middle East Oncology Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Oncology Drugs Market

    18.7.1.1. Saudi Arabia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.2. Israel Oncology Drugs Market

    18.7.2.1. Israel Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.3. Turkey Oncology Drugs Market

    18.7.3.1. Turkey Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.4. UAE Oncology Drugs Market

    18.7.4.1. UAE Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19. Africa Oncology Drugs Market

    19.1. Africa Oncology Drugs Market Overview

    19.2. Africa, Oncology Drugs Market, 2021, By Country, Value ($ Billion)

    19.3. Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    19.4. Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    19.5. Africa, Oncology Drugs Market Metrics

    19.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Africa Countries

    19.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Africa Countries

    19.6. Africa Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7. Africa Oncology Drugs Market: Country Analysis

    19.7.1. Egypt Oncology Drugs Market

    19.7.1.1. Egypt Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.2. Nigeria Oncology Drugs Market

    19.7.2.1. Nigeria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.3. South Africa Oncology Drugs Market

    19.7.3.1. South Africa Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    20. Oncology Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. F. Hoffmann-La Roche Ltd

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Novartis AG

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Gilead Sciences Inc

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Bayer AG

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Takeda Pharmaceticals

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Oncology Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Oncology Drugs Market In 2026- Growth Countries

    23.2. Global Oncology Drugs Market In 2026- Growth Segments

    23.3. Global Oncology Drugs Market In 2026- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Oncology Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4: Global Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5: Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Oncology Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12: Per Capita Average Oncology Drugs Market Expenditure, 2016-2026, Global
  • Table 13: Asia-Pacific, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Asia-Pacific Countries
  • Table 18: Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19: China Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20: China Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21: Australia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22: Australia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23: Hong Kong Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24: India Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25: India Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26: Indonesia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27: Indonesia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28: Japan Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29: Japan Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30: Malaysia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31: New Zealand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32: Philippines Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33: Singapore Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34: South Korea Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35: Thailand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36: Vietnam Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37: Western Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 38: Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 39: Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 41: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Western Europe Countries
  • Table 42: Western Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43: Austria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44: Belgium Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45: Denmark Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46: Finland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47: France Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48: France Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49: Germany Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50: Germany Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51: Ireland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52: Italy Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53: Netherlands Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54: Norway Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55: Portugal Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56: Spain Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57: Sweden Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58: Switzerland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59: UK Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60: UK Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61: Eastern Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 65: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Eastern Europe Countries
  • Table 66: Eastern Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67: Czech Republic Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68: Poland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69: Romania Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70: Russia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71: Russia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72: North America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 73: North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 74: North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Oncology Drugs Expenditure, 2016-2026, North America Countries
  • Table 76: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, North America Countries
  • Table 77: North America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78: Canada Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79: Mexico Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 80: USA Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 81: USA Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 82: South America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 83: South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 84: South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Oncology Drugs Expenditure, 2016-2026, South America Countries
  • Table 86: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, South America Countries
  • Table 87: South America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88: Argentina Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89: Brazil Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90: Brazil Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91: Chile Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92: Colombia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 93: Peru Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 94: Venezuela Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95: Middle East, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 96: Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 97: Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 99: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Middle East Countries
  • Table 100: Middle East Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 101: Saudi Arabia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102: Israel Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103: Turkey Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104: UAE Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105: Africa, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 106: Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 107: Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Africa Countries
  • Table 109: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Africa Countries
  • Table 110: Africa Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 111: Egypt Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 112: Nigeria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113: South Africa Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 115: Novartis AG Financial Performance
  • Table 116: Gilead Sciences Inc Financial Performance
  • Table 117: Bayer AG Financial Performance
  • Table 118: Takeda Pharmaceticals Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Oncology Drugs Market In 2026- Growth Countries
  • Table 124: Global Oncology Drugs Market In 2026- Growth Segments
  • Table 125: Global Oncology Drugs Market In 2026- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Oncology Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4: Global Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5: Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Oncology Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12: Per Capita Average Oncology Drugs Market Expenditure, 2016-2026, Global
  • Figure 13: Asia-Pacific, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Asia-Pacific Countries
  • Figure 18: Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19: China Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20: China Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21: Australia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22: Australia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23: Hong Kong Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24: India Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25: India Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26: Indonesia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27: Indonesia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28: Japan Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29: Japan Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30: Malaysia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31: New Zealand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32: Philippines Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33: Singapore Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34: South Korea Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35: Thailand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36: Vietnam Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37: Western Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 38: Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 39: Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 40: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 41: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Western Europe Countries
  • Figure 42: Western Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43: Austria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44: Belgium Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45: Denmark Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46: Finland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47: France Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48: France Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49: Germany Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50: Germany Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51: Ireland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52: Italy Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53: Netherlands Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54: Norway Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55: Portugal Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56: Spain Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57: Sweden Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58: Switzerland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59: UK Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60: UK Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61: Eastern Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 62: Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 63: Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 64: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 65: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Eastern Europe Countries
  • Figure 66: Eastern Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67: Czech Republic Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68: Poland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69: Romania Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70: Russia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71: Russia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72: North America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 73: North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 74: North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 75: Per Capita Average Oncology Drugs Expenditure, 2016-2026, North America Countries
  • Figure 76: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, North America Countries
  • Figure 77: North America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78: Canada Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79: Mexico Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 80: USA Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 81: USA Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 82: South America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 83: South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 84: South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 85: Per Capita Average Oncology Drugs Expenditure, 2016-2026, South America Countries
  • Figure 86: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, South America Countries
  • Figure 87: South America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88: Argentina Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89: Brazil Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90: Brazil Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91: Chile Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92: Colombia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 93: Peru Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 94: Venezuela Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95: Middle East, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 96: Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 97: Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 98: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 99: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Middle East Countries
  • Figure 100: Middle East Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 101: Saudi Arabia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102: Israel Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103: Turkey Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104: UAE Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105: Africa, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 106: Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 107: Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 108: Per Capita Average Oncology Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 109: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Africa Countries
  • Figure 110: Africa Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 111: Egypt Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 112: Nigeria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113: South Africa Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 115: Novartis AG Financial Performance
  • Figure 116: Gilead Sciences Inc Financial Performance
  • Figure 117: Bayer AG Financial Performance
  • Figure 118: Takeda Pharmaceticals Financial Performance
  • Figure 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 123: Global Oncology Drugs Market In 2026- Growth Countries
  • Figure 124: Global Oncology Drugs Market In 2026- Growth Segments
  • Figure 125: Global Oncology Drugs Market In 2026- Growth Strategies

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oncology Devices Global Market Report 2024 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oncology Molecular Diagnostics Global Market Report 2024 – By Product (Instruments, Reagents, Other Products), By Technology (Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Lung Cancer Drugs Global Market Report 2024 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Breast Cancer Drugs Global Market Report 2024 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Prostate Cancer Drugs Global Market Report 2024 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Ovarian Cancer Drugs Global Market Report 2024 – By Tumor Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), By Drug Type (Alkylating Agents, Mitotic Inhibitors, VEGF/VEGFR inhibitors, PARP inhibitors, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the oncology drugs market?

The oncology drugs market consists of sales of oncology drugs and related services by entities that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, brain tumor, and other different cancer types.  request a sample here

How will the oncology drugs market drivers and restraints affect oncology drugs market dynamics? What forces will shape the oncology drugs industry going forward?

The oncology drugs market growth is aided by companies rearranging their operations and recovering from the COVID-19 impact. However, some oncology drugs market restraints include outbreak of the coronavirus disease request a sample here

What is the forecast market size of the oncology drugs market?

The oncology drugs market forecast is expected to reach $112.14 billion in 2025 at a compound annual growth rate of 7%. request a sample here

How is the oncology drugs market segmented?

The global oncology drugs market is segmented -
1) By Type: Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the oncology drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global oncology drugs market?

Top competitors in the oncology drugs market are F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc, Bayer AG, Takeda Pharmaceticals. request a sample here.

What are the key trends in the global oncology drugs market?

Major trends influencing the oncology drugs market include investing in targeted therapy request a sample here.

What are the major opportunities in the oncology drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global oncology drugs market, request a sample here.

How does the oncology drugs market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.